| Author |
Seo S, Park MJ, Park MG, Gwak M, Kim Y, Jang J, Hong N, Lee BS, Kim C, Jo S, Shim HB, Kim HJ, Kim MH, Yoo SH, Yoon S, Kim S, Lee JH, Choi SH, Lee SY, Yeon GB, Park SH, Kim SH, Lee H, Lee JY, Kim DS, Lee BC, Park JW, Kim H.
|
| Abstract |
To elucidate the complex interplay of undifferentiated cancer cells in malignancy, we focus on the crucial mechanisms that maintain the undifferentiated state of cancer stem-like cells, which drive tumor growth and therapy resistance. Here, we identify a protein called dehydrogenase/reductase 13 (DHRS13) that is abundant in undifferentiated glioblastoma cells. DHRS13 is primarily located in the mitochondria and functions as a retinaldehyde reductase, converting all-trans-retinaldehyde to all-trans-retinol with high affinity for NADPH. Mechanistically, DHRS13 prevents glioma stem-like cells from differentiating by blocking retinoic acid signaling, thereby maintaining their undifferentiated state. Remarkably, the depletion of DHRS13 results in mitochondrial reactive oxygen species-driven mitophagy and cell death. Consequently, loss of DHRS13 leads to a significant decrease in tumor initiation and progression. These findings hold promise for the development of strategies that target undifferentiated cancer cells, potentially leading to improved treatment outcomes.
|
